1. Gupta M, Kharb P, Kalaiselvan V, Shridhar M, Singh GN, Kshirsagar N, et al. Safety of medicines: Pharmacovigilance programme of India. WHO Drug Inform 2018;32:10-7.
2. WHO Media Centre. Fact Sheet: Cardiovascular Diseases (CVDs); 2016. Available from: https://www.who.int/mediacentre/factsheets/ fs317/en [Last accessed on 2016 Oct 27].
3. Hadi MA, Neoh CF, Zin RM, Elrggal ME, Cheema E. Pharmacovigilance: Pharmacists’ perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract 2017;6:91-8. doi: 10.2147/IPRP.S105881
4. Siddarama R, Bharath Naidu J, Joshisree KP, Sahithi Lakshmi V. Polypharmacy induced drug interactions, adverse drug reactions (ADR) and medication errors in tertiary care south Indian hospital. Int J Pharm Pharm Sci 2019;11:83-93.
5. Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci 2011;16:16-25.